Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) is looking for acquisitions. Dilip Shanghvi, Managing Director of Sun Pharmaceutical Industries is now looking at new markets to fire the company's growth engine. Shanghai now plans to steer the company into the specialty business (novel, innovative drugs), and towards expanding markets like China and Japan for growth, both through acquisitions and partnerships.